Aug. 20, 2021 — The Pharmaceutical Research and Manufacturers of America (PhRMA) has “updated and enhanced” its voluntary code of ethics regarding how the drug industry can appropriately interact with U.S. health care professionals (HCPs) while marketing biopharma products in various ways, including speaker programs. PhRMA’s revised “Code on Interactions with Health Care Professionals,” last updated […]
Read moreOct. 22, 2012 – At a hearing held Friday in Boston by the Massachusetts Department of Public Health, representatives from the Coalition for Healthcare Communication, the Massachusetts Biotechnology Council (MassBio) and the Pharmaceutical Research and Manufacturers of America (PhRMA) testified that the state’s emergency amendments making an exception to a 2008 gift ban to allow […]
Read moreSept. 28, 2012 – Pharmaceutical and medical device companies may be allowed to provide “modest meals and refreshments” at non-continuing medical education (CME) events in Massachusetts if proposed “emergency amendments” to the state’s law covering codes of conduct for these industries are adopted. An Oct. 19 hearing is planned to discuss the amendments. In July, […]
Read more